ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 745451 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 745451; 2) Community: the network communities that were significantly associated with the response to NSC 745451; 3) Molecule: the relationships between components within communities and NSC 745451; 4) MDR: the compounds that were significantly associated with the NSC 745451.

NSC Compound Enrichment Correlation
NSC 113951 6-Bromotoyocamycin 0.0376362543535812 0.52621923
NSC 127755 Benzenesulfonyl fluoride, 3-chloro-4-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]butyl]-, monoethanesulfonate (9CI) 0.0376362543535812 0.22646983
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0376362543535812 0.37955764
NSC 351078 Hydrazinecarbothioamide, N,N-dimethyl-2-[1-(2-pyridinyl)- ethylidene]-, N-oxide 0.0376362543535812 0.42873533
NSC 359892 2,6-Epoxy-2H-1-benzoxocin-5(6H)-one, 6,8-dimethyl- 0.0376362543535812 0.54296518
NSC 363812 Tetraplatin 0.0376362543535812 0.41841498
NSC 610458 Camptothecin Derivative 0.0376362543535812 0.18521594
NSC 621336 Null 0.0376362543535812 0.45687902
NSC 624771 5H-Benzocyclohepten-5-one, 4-(acetyloxy)-6,6-dibromo- 6,7,8,9-tetrahydro- 0.0376362543535812 0.42681839
NSC 626163 Discorhabdin C-nitrodienone . TFA 0.0376362543535812 0.22830441
Total:139  Current:106    [First] [Prev] [Next] [Last]